TreeWAS – Variant ID: rs11209261

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.094	0.906	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.088	0.912	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.088	0.912	0.000
I71 Aortic aneurysm and dissection	0.087	0.913	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.084	0.916	0.000
I70 Atherosclerosis	0.084	0.916	0.000
I70-I79 Diseases of arteries, arterioles and capillaries	0.079	0.921	0.000
I77 Other disorders of arteries and arterioles	0.076	0.924	0.000
I77.6 Arteritis, unspecified	0.073	0.927	0.000
I77.1 Stricture of artery	0.069	0.931	0.000
I70.0 Atherosclerosis of aorta	0.068	0.932	0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.068	0.932	0.000
I71.1 Thoracic aortic aneurysm, ruptured	0.067	0.933	0.000
I77.8 Other specified disorders of arteries and arterioles	0.066	0.934	0.000
I71.0 Dissection of aorta [any part]	0.063	0.937	0.000
I70.8 Atherosclerosis of other arteries	0.063	0.937	0.000
I71.8 Aortic aneurysm of unspecified site, ruptured	0.062	0.938	0.000
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.062	0.938	0.000
I70.9 Generalised and unspecified atherosclerosis	0.062	0.938	0.000
I77.3 Arterial fibromuscular dysplasia	0.062	0.938	0.000
C61 Malignant neoplasm of prostate	0.060	0.940	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.057	0.942	0.000
I70.1 Atherosclerosis of renal artery	0.057	0.943	0.000
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.056	0.943	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.056	0.944	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.055	0.945	0.000
I77.5 Necrosis of artery	0.055	0.945	0.000
I77.4 Coeliac artery compression syndrome	0.055	0.945	0.000
I72 Other aneurysm	0.055	0.945	0.000
I77.0 Arteriovenous fistula, acquired	0.049	0.950	0.000
I70.01 Atherosclerosis of aorta (with gangrene)	0.049	0.951	0.000
I70.80 Atherosclerosis of other arteries (without gangrene)	0.047	0.952	0.000
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.046	0.954	0.000
I70.81 Atherosclerosis of other arteries (with gangrene)	0.045	0.955	0.000
I72.3 Aneurysm of iliac artery	0.045	0.955	0.000
I73 Other peripheral vascular diseases	0.045	0.955	0.000
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.044	0.955	0.000
I72.4 Aneurysm of artery of lower extremity	0.044	0.956	0.000
I72.8 Aneurysm of other specified arteries	0.043	0.957	0.000
I72.1 Aneurysm of artery of upper extremity	0.042	0.958	0.000
I70.11 Atherosclerosis of renal artery (with gangrene)	0.041	0.959	0.000
I72.5 Aneurysm and dissection of other precerebral arteries	0.041	0.959	0.000
N81.6 Rectocele	0.000	0.960	0.040
I72.9 Aneurysm of unspecified site	0.039	0.960	0.000
I72.6 Aneurysm and dissection of vertebral artery	0.039	0.961	0.000
I70.10 Atherosclerosis of renal artery (without gangrene)	0.038	0.962	0.000
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.038	0.962	0.000
I77.2 Rupture of artery	0.037	0.963	0.000
I73.9 Peripheral vascular disease, unspecified	0.035	0.965	0.000
I73.8 Other specified peripheral vascular diseases	0.033	0.967	0.000
I77.9 Disorder of arteries and arterioles, unspecified	0.032	0.968	0.000
I73.1 Thromboangiitis obliterans [Buerger]	0.029	0.971	0.000
I74 Arterial embolism and thrombosis	0.028	0.972	0.000
N81 Female genital prolapse	0.000	0.972	0.028
C60-C63 Malignant neoplasms of male genital organs	0.028	0.972	0.000
I79.1 Aortitis in diseases classified elsewhere	0.027	0.972	0.000
I79.0 Aneurysm of aorta in diseases classified elsewhere	0.027	0.972	0.000
I72.2 Aneurysm of renal artery	0.027	0.973	0.000
N81.3 Complete uterovaginal prolapse	0.000	0.973	0.027
N81.1 Cystocele	0.000	0.974	0.026
I74.9 Embolism and thrombosis of unspecified artery	0.025	0.975	0.000
I78 Diseases of capillaries	0.023	0.976	0.001
N81.5 Vaginal enterocele	0.000	0.976	0.024
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.023	0.976	0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.023	0.977	0.000
N81.4 Uterovaginal prolapse, unspecified	0.000	0.978	0.022
C62 Malignant neoplasm of testis	0.022	0.978	0.000
I73.0 Raynaud's syndrome	0.021	0.979	0.000
N81.0 Female urethrocele	0.000	0.979	0.021
C60 Malignant neoplasm of penis	0.020	0.980	0.000
I74.0 Embolism and thrombosis of abdominal aorta	0.020	0.980	0.000
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.019	0.980	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.019	0.981	0.000
I78.9 Disease of capillaries, unspecified	0.018	0.981	0.001
C62.9 Testis, unspecified	0.019	0.981	0.000
I74.8 Embolism and thrombosis of other arteries	0.018	0.982	0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.000	0.983	0.017
N81.8 Other female genital prolapse	0.000	0.983	0.017
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.016	0.984	0.001
I72.0 Aneurysm of carotid artery	0.015	0.984	0.001
I74.5 Embolism and thrombosis of iliac artery	0.016	0.984	0.000
C60.1 Glans penis	0.016	0.984	0.000
C62.0 Undescended testis	0.016	0.984	0.000
D37.4 Colon	0.016	0.984	0.000
C60.0 Prepuce	0.015	0.984	0.000
C60.8 Overlapping lesion of penis	0.015	0.985	0.000
C60.2 Body of penis	0.015	0.985	0.000
I78.0 Hereditary haemorrhagic telangiectasia	0.014	0.985	0.001
I78.8 Other diseases of capillaries	0.013	0.986	0.001
C62.1 Descended testis	0.014	0.986	0.000
C63.9 Male genital organ, unspecified	0.014	0.986	0.000
C63.8 Overlapping lesion of male genital organs	0.014	0.986	0.000
C63.7 Other specified male genital organs	0.014	0.986	0.000
C63.1 Spermatic cord	0.014	0.986	0.000
C63.0 Epididymis	0.014	0.986	0.000
C63.2 Scrotum	0.013	0.987	0.000
C60.9 Penis, unspecified	0.013	0.987	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.013	0.987	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.012	0.988	0.000
D37.7 Other digestive organs	0.012	0.988	0.000
D37.3 Appendix	0.010	0.989	0.000
N81.9 Female genital prolapse, unspecified	0.000	0.990	0.010
I49.1 Atrial premature depolarisation	0.000	0.990	0.010
D37.0 Lip, oral cavity and pharynx	0.010	0.990	0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.009	0.990	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.010	0.990	0.000
D37.1 Stomach	0.010	0.990	0.000
D37.2 Small intestine	0.009	0.990	0.000
D37.5 Rectum	0.009	0.991	0.000
D37.6 Liver, gallbladder and bile ducts	0.009	0.991	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.992	0.000
N81.2 Incomplete uterovaginal prolapse	0.000	0.992	0.008
T43.6 Psychostimulants with abuse potential	0.008	0.992	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.008	0.992	0.000
T43.2 Other and unspecified antidepressants	0.008	0.992	0.000
D37.9 Digestive organ, unspecified	0.007	0.993	0.000
I49 Other cardiac arrhythmias	0.000	0.993	0.007
I49.8 Other specified cardiac arrhythmias	0.000	0.993	0.007
T43.8 Other psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
T43.9 Psychotropic drug, unspecified	0.007	0.993	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.007	0.993	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.007	0.993	0.000
I49.0 Ventricular fibrillation and flutter	0.000	0.993	0.007
T43.4 Butyrophenone and thioxanthene neuroleptics	0.007	0.993	0.000
I49.3 Ventricular premature depolarisation	0.000	0.994	0.006
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.000	0.994	0.006
I49.2 Junctional premature depolarisation	0.000	0.994	0.005
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
I49.5 Sick sinus syndrome	0.000	0.995	0.005
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
I35.9 Aortic valve disorder, unspecified	0.000	0.995	0.005
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.005	0.995	0.000
T36 Poisoning by systemic antibiotics	0.004	0.995	0.000
I49.4 Other and unspecified premature depolarisation	0.000	0.996	0.004
M94.88 Other specified disorders of cartilage (Other)	0.000	0.996	0.004
M94.8 Other specified disorders of cartilage	0.000	0.996	0.004
T40.6 Other and unspecified narcotics	0.004	0.996	0.000
T36.0 Penicillins	0.004	0.996	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.000	0.996	0.004
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
C71.3 Parietal lobe	0.000	0.996	0.004
M94.86 Other specified disorders of cartilage (Lower leg)	0.000	0.996	0.004
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T47.2 Stimulant laxatives	0.004	0.996	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.004	0.996	0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.000	0.996	0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
I78.1 Naevus, nonneoplastic	0.001	0.996	0.003
T36.8 Other systemic antibiotics	0.004	0.996	0.000
T40.4 Other synthetic narcotics	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
C71.1 Frontal lobe	0.000	0.996	0.004
T47.4 Other laxatives	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T40.1 Heroin	0.004	0.996	0.000
C71 Malignant neoplasm of brain	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.003	0.996	0.000
T36.3 Macrolides	0.003	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.996	0.000
T40.5 Cocaine	0.003	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.996	0.000
T47.7 Emetics	0.003	0.996	0.000
T47.5 Digestants	0.003	0.996	0.000
T47.3 Saline and osmotic laxatives	0.003	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.996	0.000
T36.6 Rifamycins	0.003	0.996	0.000
T36.5 Aminoglycosides	0.003	0.996	0.000
T36.2 Chloramphenicol group	0.003	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.996	0.000
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.000	0.997	0.003
M94.84 Other specified disorders of cartilage (Hand)	0.000	0.997	0.003
M94.83 Other specified disorders of cartilage (Forearm)	0.000	0.997	0.003
M94.82 Other specified disorders of cartilage (Upper arm)	0.000	0.997	0.003
M94.80 Other specified disorders of cartilage (Multiple sites)	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
C71.9 Brain, unspecified	0.000	0.997	0.003
C71.2 Temporal lobe	0.000	0.997	0.003
N05.9 Unspecified	0.003	0.997	0.000
S60.9 Superficial injury of wrist and hand, unspecified	0.003	0.997	0.000
A49.0 Staphylococcal infection, unspecified	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
K29.7 Gastritis, unspecified	0.000	0.997	0.003
T36.4 Tetracyclines	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
T45.5 Anticoagulants	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
N18.9 Chronic renal failure, unspecified	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T40.3 Methadone	0.003	0.997	0.000
M94 Other disorders of cartilage	0.000	0.997	0.003
I49.9 Cardiac arrhythmia, unspecified	0.000	0.997	0.003
M94.81 Other specified disorders of cartilage (Shoulder region)	0.000	0.997	0.003
T42.4 Benzodiazepines	0.003	0.997	0.000
N05.8 Other	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
C71.7 Brain stem	0.000	0.997	0.003
T42.3 Barbiturates	0.003	0.997	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.997	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.997	0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)	0.000	0.997	0.003
T42.0 Hydantoin derivatives	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
F31 Bipolar affective disorder	0.003	0.997	0.000
M94.2 Chondromalacia	0.000	0.997	0.003
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
C71.0 Cerebrum, except lobes and ventricles	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
N05 Unspecified nephritic syndrome	0.003	0.997	0.000
R42 Dizziness and giddiness	0.000	0.997	0.003
F31.6 Bipolar affective disorder, current episode mixed	0.003	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.997	0.000
C71.5 Cerebral ventricle	0.000	0.997	0.003
N05.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
M94.26 Chondromalacia (Lower leg)	0.000	0.997	0.003
F31.9 Bipolar affective disorder, unspecified	0.003	0.997	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
C71.6 Cerebellum	0.000	0.997	0.003
M94.9 Disorder of cartilage, unspecified	0.000	0.997	0.003
F31.7 Bipolar affective disorder, currently in remission	0.003	0.997	0.000
T42.1 Iminostilbenes	0.003	0.997	0.000
L53.9 Erythematous condition, unspecified	0.000	0.997	0.003
B98 Other specified infectious agents as the cause of diseases classified to other chapters	0.000	0.997	0.003
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.003	0.997	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.003	0.997	0.000
C71.8 Overlapping lesion of brain	0.000	0.997	0.002
K70.3 Alcoholic cirrhosis of liver	0.000	0.997	0.003
T51.0 Ethanol	0.003	0.997	0.000
Q27.3 Peripheral arteriovenous malformation	0.003	0.997	0.000
M94.0 Chondrocostal junction syndrome [Tietze]	0.000	0.997	0.002
S82.10 Fracture of upper end of tibia (closed)	0.003	0.997	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.002	0.997	0.000
M94.3 Chondrolysis	0.000	0.997	0.002
M94.1 Relapsing polychondritis	0.000	0.997	0.002
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.997	0.000
S43.0 Dislocation of shoulder joint	0.002	0.998	0.000
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.000	0.998	0.002
F31.8 Other bipolar affective disorders	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
M94.96 Disorder of cartilage, unspecified (Lower leg)	0.000	0.998	0.002
K70.0 Alcoholic fatty liver	0.000	0.998	0.002
R23.8 Other and unspecified skin changes	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.000	0.998	0.002
Q27 Other congenital malformations of peripheral vascular system	0.002	0.998	0.000
M94.29 Chondromalacia (Site unspecified)	0.000	0.998	0.002
M94.28 Chondromalacia (Other)	0.000	0.998	0.002
M94.27 Chondromalacia (Ankle and foot)	0.000	0.998	0.002
M94.25 Chondromalacia (Pelvic region and thigh)	0.000	0.998	0.002
M94.24 Chondromalacia (Hand)	0.000	0.998	0.002
M94.23 Chondromalacia (Forearm)	0.000	0.998	0.002
M94.22 Chondromalacia (Upper arm)	0.000	0.998	0.002
M94.21 Chondromalacia (Shoulder region)	0.000	0.998	0.002
M94.20 Chondromalacia (Multiple sites)	0.000	0.998	0.002
N05.6 Dense deposit disease	0.002	0.998	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N05.0 Minor glomerular abnormality	0.002	0.998	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.002	0.998	0.000
N05.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
C71.4 Occipital lobe	0.000	0.998	0.002
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.002	0.998	0.000
M94.99 Disorder of cartilage, unspecified (Site unspecified)	0.000	0.998	0.002
M94.98 Disorder of cartilage, unspecified (Other)	0.000	0.998	0.002
M94.97 Disorder of cartilage, unspecified (Ankle and foot)	0.000	0.998	0.002
M94.95 Disorder of cartilage, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M94.94 Disorder of cartilage, unspecified (Hand)	0.000	0.998	0.002
M94.93 Disorder of cartilage, unspecified (Forearm)	0.000	0.998	0.002
M94.92 Disorder of cartilage, unspecified (Upper arm)	0.000	0.998	0.002
M94.91 Disorder of cartilage, unspecified (Shoulder region)	0.000	0.998	0.002
M94.90 Disorder of cartilage, unspecified (Multiple sites)	0.000	0.998	0.002
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N40 Hyperplasia of prostate	0.002	0.998	0.000
M94.09 Chondrocostal junction syndrome [Tietze]-Site unspec	0.000	0.998	0.002
K70 Alcoholic liver disease	0.000	0.998	0.002
Q27.8 Other specified congenital malformations of peripheral vascular system	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
N05.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
B98.1 Vibrio vulnificus as the cause of diseases classified to other chapters	0.000	0.998	0.002
K70.9 Alcoholic liver disease, unspecified	0.000	0.998	0.002
M94.07 Chondrocostal junction syndrome [Tietze]-Ankle/foot	0.000	0.998	0.002
M94.06 Chondrocostal junction syndrome [Tietze]-Lower leg	0.000	0.998	0.002
M94.05 Chondrocostal junction syndrome [Tietze]-Pelvic/thigh	0.000	0.998	0.002
M94.04 Chondrocostal junction syndrome [Tietze]-Hand	0.000	0.998	0.002
M94.03 Chondrocostal junction syndrome [Tietze]-Forearm	0.000	0.998	0.002
M94.02 Chondrocostal junction syndrome [Tietze]-Upper arm	0.000	0.998	0.002
M94.01 Chondrocostal junction syndrome [Tietze]-Shldr region	0.000	0.998	0.002
M94.00 Chondrocostal junction syndrome [Tietze]-Mult sites	0.000	0.998	0.002
E10.9 Without complications	0.000	0.998	0.002
K70.2 Alcoholic fibrosis and sclerosis of liver	0.000	0.998	0.002
Z87.2 Personal history of diseases of the skin and subcutaneous tissue	0.000	0.998	0.002
M94.19 Relapsing polychondritis (Site unspecified)	0.000	0.998	0.002
M94.18 Relapsing polychondritis (Other)	0.000	0.998	0.002
M94.17 Relapsing polychondritis (Ankle and foot)	0.000	0.998	0.002
M94.16 Relapsing polychondritis (Lower leg)	0.000	0.998	0.002
M94.15 Relapsing polychondritis (Pelvic region and thigh)	0.000	0.998	0.002
M94.14 Relapsing polychondritis (Hand)	0.000	0.998	0.002
M94.13 Relapsing polychondritis (Forearm)	0.000	0.998	0.002
M94.12 Relapsing polychondritis (Upper arm)	0.000	0.998	0.002
M94.11 Relapsing polychondritis (Shoulder region)	0.000	0.998	0.002
M94.10 Relapsing polychondritis (Multiple sites)	0.000	0.998	0.002
M94.39 Chondrolysis (Site unspecified)	0.000	0.998	0.002
M94.38 Chondrolysis (Other)	0.000	0.998	0.002
M94.37 Chondrolysis (Ankle and foot)	0.000	0.998	0.002
M94.36 Chondrolysis (Lower leg)	0.000	0.998	0.002
M94.35 Chondrolysis (Pelvic region and thigh)	0.000	0.998	0.002
M94.34 Chondrolysis (Hand)	0.000	0.998	0.002
M94.33 Chondrolysis (Forearm)	0.000	0.998	0.002
M94.32 Chondrolysis (Upper arm)	0.000	0.998	0.002
M94.31 Chondrolysis (Shoulder region)	0.000	0.998	0.002
M94.30 Chondrolysis (Multiple sites)	0.000	0.998	0.002
M94.08 Chondrocostal junction syndrome [Tietze]-Other	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
Q27.4 Congenital phlebectasia	0.002	0.998	0.000
Q27.2 Other congenital malformations of renal artery	0.002	0.998	0.000
Q27.1 Congenital renal artery stenosis	0.002	0.998	0.000
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
R23.4 Changes in skin texture	0.002	0.998	0.000
R80 Isolated proteinuria	0.002	0.998	0.000
I46.0 Cardiac arrest with successful resuscitation	0.000	0.998	0.002
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.002	0.998	0.000
N82.3 Fistula of vagina to large intestine	0.000	0.998	0.002
S01.0 Open wound of scalp	0.000	0.998	0.002
G70.0 Myasthenia gravis	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.001	0.998	0.000
T44.0 Anticholinesterase agents	0.001	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
A49.1 Streptococcal infection, unspecified	0.000	0.998	0.002
D23.9 Skin, unspecified	0.000	0.998	0.002
L73.9 Follicular disorder, unspecified	0.002	0.998	0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
F43.2 Adjustment disorders	0.002	0.998	0.000
Q28.3 Other malformations of cerebral vessels	0.002	0.998	0.000
A49 Bacterial infection of unspecified site	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.001	0.998	0.000
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
N36.0 Urethral fistula	0.000	0.998	0.002
K74.0 Hepatic fibrosis	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.001	0.998	0.000
T50.8 Diagnostic agents	0.001	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.001	0.998	0.000
Q28 Other congenital malformations of circulatory system	0.002	0.998	0.000
G93.1 Anoxic brain damage, not elsewhere classified	0.000	0.998	0.002
M19.13 Post-traumatic arthrosis of other joints (Forearm)	0.000	0.998	0.002
C69.6 Orbit	0.000	0.998	0.002
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.998	0.002
B37.9 Candidiasis, unspecified	0.000	0.998	0.002
E10.8 With unspecified complications	0.000	0.998	0.002
H81.2 Vestibular neuronitis	0.000	0.998	0.002
N13.5 Kinking and stricture of ureter without hydronephrosis	0.000	0.998	0.002
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.000	0.998	0.002
Q20-Q28 Congenital malformations of the circulatory system	0.002	0.998	0.000
N82.4 Other female intestinal-genital tract fistulae	0.000	0.998	0.002
Q21.1 Atrial septal defect	0.002	0.998	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.001	0.998	0.001
A49.9 Bacterial infection, unspecified	0.000	0.998	0.002
Q23.0 Congenital stenosis of aortic valve	0.002	0.998	0.000
K70.1 Alcoholic hepatitis	0.000	0.998	0.002
N82.0 Vesicovaginal fistula	0.000	0.998	0.002
S80.8 Other superficial injuries of lower leg	0.000	0.998	0.002
Q25 Congenital malformations of great arteries	0.002	0.998	0.000
R23 Other skin changes	0.002	0.998	0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.000	0.998	0.002
C69 Malignant neoplasm of eye and adnexa	0.000	0.998	0.002
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
A49.3 Mycoplasma infection, unspecified	0.000	0.998	0.001
M19.1 Posttraumatic arthrosis of other joints	0.000	0.998	0.002
Z89.6 Acquired absence of leg above knee	0.002	0.998	0.000
G44.0 Cluster headache syndrome	0.000	0.998	0.002
O14.1 Severe preeclampsia	0.000	0.998	0.002
T21.0 Burn of unspecified degree of trunk	0.000	0.998	0.002
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
E88.2 Lipomatosis, not elsewhere classified	0.002	0.998	0.000
H02.5 Other disorders affecting eyelid function	0.002	0.998	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.001	0.998	0.000
Z08 Follow-up examination after treatment for malignant neoplasm	0.000	0.998	0.002
M22.2 Patellofemoral disorders	0.002	0.998	0.000
K82.4 Cholesterolosis of gallbladder	0.002	0.998	0.000
Q28.9 Congenital malformation of circulatory system, unspecified	0.001	0.998	0.000
Q28.8 Other specified congenital malformations of circulatory system	0.001	0.998	0.000
Q28.1 Other malformations of precerebral vessels	0.001	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.001	0.998	0.000
N82 Fistulae involving female genital tract	0.000	0.998	0.002
S60 Superficial injury of wrist and hand	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
H20.0 Acute and subacute iridocyclitis	0.001	0.998	0.000
Q23.3 Congenital mitral insufficiency	0.001	0.998	0.000
Z29.8 Other specified prophylactic measures	0.000	0.998	0.002
C69.4 Ciliary body	0.000	0.998	0.001
J04.0 Acute laryngitis	0.000	0.998	0.001
K00.6 Disturbances in tooth eruption	0.001	0.998	0.000
Q25.3 Stenosis of aorta	0.001	0.998	0.000
R23.2 Flushing	0.001	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.001	0.998	0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.000	0.998	0.001
Z63.0 Problems in relationship with spouse or partner	0.001	0.998	0.000
E10 Insulin-dependent diabetes mellitus	0.000	0.998	0.002
Q20 Congenital malformations of cardiac chambers and connexions	0.001	0.998	0.000
A49.2 Haemophilus influenzae infection, unspecified	0.000	0.999	0.001
D89.2 Hypergammaglobulinaemia, unspecified	0.000	0.999	0.001
K70.4 Alcoholic hepatic failure	0.000	0.999	0.001
Q25.1 Coarctation of aorta	0.001	0.999	0.000
Q25.0 Patent ductus arteriosus	0.001	0.999	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.001	0.999	0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.001	0.999	0.000
C70 Malignant neoplasm of meninges	0.000	0.999	0.001
Q26 Congenital malformations of great veins	0.001	0.999	0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.000	0.999	0.001
L91.0 Keloid scar	0.000	0.999	0.001
T21 Burn and corrosion of trunk	0.000	0.999	0.001
C69.8 Overlapping lesion of eye and adnexa	0.000	0.999	0.001
C69.5 Lachrymal gland and duct	0.000	0.999	0.001
C69.1 Cornea	0.000	0.999	0.001
Q25.9 Congenital malformation of great arteries, unspecified	0.001	0.999	0.000
Q25.8 Other congenital malformations of great arteries	0.001	0.999	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.001	0.999	0.000
Q25.6 Stenosis of pulmonary artery	0.001	0.999	0.000
Q25.5 Atresia of pulmonary artery	0.001	0.999	0.000
Q25.2 Atresia of aorta	0.001	0.999	0.000
Q21 Congenital malformations of cardiac septa	0.001	0.999	0.000
M19.19 Post-traumatic arthrosis of other joints (Site unspecified)	0.000	0.999	0.001
M19.18 Post-traumatic arthrosis of other joints (Other)	0.000	0.999	0.001
M19.16 Post-traumatic arthrosis of other joints-Lower leg	0.000	0.999	0.001
M19.15 Post-traumatic arthrosis of other joints (Pelvic region and thigh)	0.000	0.999	0.001
M19.10 Post-traumatic arthrosis of other joints (Multiple sites)	0.000	0.999	0.001
C69.9 Eye, unspecified	0.000	0.999	0.001
E10.3 With ophthalmic complications	0.000	0.999	0.001
N82.8 Other female genital tract fistulae	0.000	0.999	0.001
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.001	0.999	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.001	0.999	0.000
Q23.4 Hypoplastic left heart syndrome	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations